The Cardiovascular Division focuses on the development, manufacturing, and distribution of medicines for the prevention and treatment of cardiovascular diseases. Operating under GMP-certified manufacturing facilities and in compliance with DRAP regulations and the Drug Licensing Management (DML) Rules 2019, the division is committed to delivering safe, effective, and high-quality healthcare solutions.
The division's portfolio addresses a wide range of cardiovascular conditions, including hypertension, ischemic heart disease, angina pectoris, heart failure, dyslipidemia, and thromboembolic disorders. Through innovation, quality assurance, and patient-centered care, the division provides healthcare professionals with trusted therapies that help reduce cardiovascular risks and improve patient outcomes.
Main Products
- Amlodipine Tablets
- Amlodipine + Valsartan Tablets
- Losartan Tablets
- Telmisartan Tablets
- Bisoprolol Tablets
- Atenolol Tablets
- Rosuvastatin Tablets
- Atorvastatin Tablets
- Clopidogrel Tablets
- Aspirin Low-Dose Tablets
Featured Product – Amlodipine
Amlodipine is a calcium channel blocker indicated for the treatment of hypertension and angina. It works by relaxing blood vessels, improving blood flow, and reducing the workload on the heart, thereby helping to control blood pressure and reduce the risk of cardiovascular complications.